Literature DB >> 2664092

Demyelination in spinal cord injury.

S G Waxman1.   

Abstract

Morphological and physiological studies demonstrate that demyelination constitutes a significant component of the pathology in compressive spinal cord injury. In many cases of spinal cord injury, a rim of demyelinated axons surrounds a central core of hemorrhagic necrosis. This provides a pathophysiological basis for "discomplete" spinal cord injuries, characterized by apparently complete transection as judged by clinical criteria, but with neurophysiological evidence of conduction through the level of damage. Recovery of conduction in demyelinated axons may permit recovery of function, and can be mediated by several mechanisms, including remyelination by oligodendrocytes or Schwann cells. Alternatively, conduction of action potentials can occur in the absence of remyelination, but this requires plasticity of the demyelinated axon. The biophysics of conduction favors recovery of electrogenesis after demyelination of small diameter axons. This may account, in part, for the observation that functional recovery is more common after demyelination of visual, compared to spinal, axons. Restoration or modification of conduction in demyelinated fibers represents an important strategy for promoting functional recovery in spinal cord injury.

Entities:  

Mesh:

Year:  1989        PMID: 2664092     DOI: 10.1016/0022-510x(89)90072-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  42 in total

Review 1.  A systematic review of the effects of pharmacological agents on walking function in people with spinal cord injury.

Authors:  Antoinette Domingo; Abdulaziz A Al-Yahya; Yousif Asiri; Janice J Eng; Tania Lam
Journal:  J Neurotrauma       Date:  2012-02-29       Impact factor: 5.269

Review 2.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

Review 3.  Potassium channel blockers as an effective treatment to restore impulse conduction in injured axons.

Authors:  Riyi Shi; Wenjing Sun
Journal:  Neurosci Bull       Date:  2011-02       Impact factor: 5.203

4.  Paranodal myelin damage after acute stretch in Guinea pig spinal cord.

Authors:  Wenjing Sun; Yan Fu; Yuzhou Shi; Ji-Xin Cheng; Peng Cao; Riyi Shi
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

Review 5.  Zebrafish as a model to investigate CNS myelination.

Authors:  Marnie A Preston; Wendy B Macklin
Journal:  Glia       Date:  2014-09-27       Impact factor: 7.452

Review 6.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

7.  Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells.

Authors:  Qilin Cao; Xiao-Ming Xu; William H Devries; Gaby U Enzmann; Peipei Ping; Pantelis Tsoulfas; Patrick M Wood; Mary Bartlett Bunge; Scott R Whittemore
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

8.  Axonal remyelination by cord blood stem cells after spinal cord injury.

Authors:  Venkata Ramesh Dasari; Daniel G Spomar; Christopher S Gondi; Christopher A Sloffer; Kay L Saving; Meena Gujrati; Jasti S Rao; Dzung H Dinh
Journal:  J Neurotrauma       Date:  2007-02       Impact factor: 5.269

Review 9.  Imaging techniques in spinal cord injury.

Authors:  Benjamin M Ellingson; Noriko Salamon; Langston T Holly
Journal:  World Neurosurg       Date:  2012-12-12       Impact factor: 2.104

Review 10.  Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.

Authors:  Christopher S Ahuja; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-04-29       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.